Vocal Biomarkers Market Proliferation Can Be Easier with Rising Cases of Depression
Vocal Biomarkers Market information: by type (frequency, amplitude, error rate, vocal rise or fall time, phonation time, voice tremor, pitch, others) by indications (psychiatric disorders (depression, Attention Deficit and Disruptive Behavior Disorders, others), neurological disorders (Parkinson's disease (PD), Alzheimer's disease, Huntington's disease, others), Respiratory Disorders, Cardiovascular Disorders, traumatic brain injury (TBI), others), others) by end users (hospitals and clinics, academic and research, others) - Global Forecast till 2027
Overview:
The vocal biomarker markets can achieve better growth in the coming years due to its non-invasive methods in detecting diseases. This is going to ensure better growth for the market. The demand for the detection of various psychological disorders is rising and voice biomarkers can play a crucial role in triggering growth. The global market for voice biomarkers can be on a track to achieve a CAGR of 14.5% to surpass a valuation of USD 2.5 million between 2017 and 2023, which according to the Market Research Future (MRFR), is the forecast period. Its impact on the detection of several diseases like neurological and others, using the understanding of speech inconsistencies, is massive. In cases of Parkinson's disease (PD), Attention Deficit & Disruptive Behavior Disorders, Huntington's disease, Respiratory & Cardiovascular Disorders, Alzheimer's disease, traumatic brain injury (TBI) etc. its inclusion would ensure higher growth.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3933
Segments:
The global report on the market for vocal biomarkers facilitates a study by providing a segmentation on the basis of indications, type, and end users. This sort of segmentation can improve the market scenario in the coming years as it would reveal various market dynamics and growth opportunities, which the players can explore.
By type, the market report has been segmented into amplitude, frequency, vocal rise or fall time, error rate, voice tremor, pitch, phonation time, and others.
By indications, the market on the vocal biomarkers can be segmented on the basis of psychiatric disorders (attention deficit & disruptive behavior disorders, depression, others), neurological disorders (Huntington's disease, Alzheimer's disease, Parkinson’s disease (PD), others), traumatic brain injury (TBI), cardiovascular disorders, respiratory disorders, and others.
By end users, the market report on the vocal biomarkers comprises academic & research hospitals & clinics, and others. The academic & research segment has a high scope for growth as the system has a lot to develop in order to grow at a faster rate.
Regional analysis
The global market for voice biomarkers is mostly getting traction from North America. Advanced research opportunities, better growth planning, hike in investment, participation from various research institutes, and others are going to lead the voice biomarker market ahead. This growth would get the maximum traction from the US as its better infrastructure and favorable reimbursement scenarios can improve the market uptake. In South America, the growth opportunity would gain lesser acknowledgments as the backups needed to make sure of the market growth are not well-formed. In Europe, the growth would be assuring as countries like France, Germany, Russia, the UK, and others are going to display huge potential. Better infrastructure and a tendency to invest much in the research & development are expected to form the premise for this regional market growth. In the Asia Pacific region, this growth would be ensured by countries like Japan, China, and India. Revamping healthcare sectors in these countries are going to foster growth.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/vocal-biomarkers-market-3933
Competitive Landscape:
A lot of players in the healthcare sector are trying to come up with solutions regarding diseases that would be non-invasive and less cumbersome. This has triggered the need for treatment procedures that would judge a person on the basis of their behavioral traits. The recent developments in the voice biomarker market are getting applauds as it can diagnose diseases in such ways. Players to impact the market are Cogito Corporation, Sonde Health, Beyond Verbal, IBM Corporation, Audio Profiling, and others.
In December 2019, Beyond Verbal and Healthymize revealed their plan to merge and form Newton, Mass.-based Vocalis Health. To do that they have raised USD 9 million to fetch additional data. This would help them in building a solid base that would support the market growth.
In November 2019, Sonde Health Inc. announced that they have received a foundational patent for their voice biomarker technology from the United States Patent and Trademark Office.
You may also be interested in...
Global Cancer Biomarker Market Research Report Forecast till 2027
Tumor Necrosis Factor Alpha Inhibitors Market Research Report Global Forecast Till 2027
Global Acute Coronary Syndrome Market Research Report Global Forecast Till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
